Paul Peter Tak - Nov 26, 2023 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Chief Executive Officer, Director
Signature
/s/ Jason Amello, as Attorney-in-Fact for Paul Peter Tak
Stock symbol
CADL
Transactions as of
Nov 26, 2023
Transactions value $
$0
Form type
4
Date filed
11/28/2023, 04:30 PM
Previous filing
May 2, 2023
Next filing
Nov 30, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CADL Common Stock Award $0 +180K +76.03% $0.00 417K Nov 26, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting and settlement. 50% of the RSUs shall vest on June 30, 2024, and the remaining 50% on December 31, 2024, in each case subject to the Reporting Person's continued service on such vesting date.